Format

Send to

Choose Destination
Haematologica. 2015 Nov;100(11):e482. doi: 10.3324/haematol.2015.134288.

Response to comment by P. Vassilakopoulos and colleagues.

Author information

1
Medical University of Vienna, Innsbruck, Austria ulrich.jaeger@meduniwien.ac.at.
2
Assign Data Management and Biostatistics GmbH Assign Group, Innsbruck, Austria.
3
Private Medical University Hospital Salzburg, Austria.

KEYWORDS:

aggressive B-cell lymphoma; first remission; randomized trial; rituximab maintenance

PMID:
26521299
PMCID:
PMC4825306
DOI:
10.3324/haematol.2015.134288
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center